(Elena) Hsieh, MD - Clinical Immunology Society
(Elena) Hsieh, MD - Clinical Immunology Society
(Elena) Hsieh, MD - Clinical Immunology Society
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
An Infant in Septic Shock:Immunodeficiency vs.Infection?<strong>Elena</strong> <strong>Hsieh</strong>, <strong>MD</strong>Allergy and <strong>Immunology</strong>Stanford University
History• ID: 4mo old, ex-full term boy, intermittent feversfor 2 months• Chief Complaint: progressively worse abdominaldistention, non-bilious emesis• Social History: No travel. No sick contacts.• Family History: Healthy sibling. Parents denyconsanguinity, but both from village in Michoacan,Mexico. Maternal cousin died of unknown cause asan infant
Initial <strong>Clinical</strong> Course• Physical Exam: Shotty cervical LAD bilaterally,hepatosplenomegaly, anasarca, no rashes• Labs: Metabolic acidosis, leukocytosis, DIC• Paracentesis: cx + bacillus IV antibiotics• Change of mental statusintubation and ionotropicsupport PICU• LP: WBC 11 (polys 1, lymph 68, mono 31), glucose75, protein 318, RBC 15
Brain MRIAbdominal & PelvicMRI
Differential Diagnosis13.212.598PMNs: 3%Bands: 16%35.3Lymphs: 40%• Possible diagnoses?• Additional laboratory testing?• Additional imaging studies?
Laboratory Results• CRP: 4.70.6• QUIGs: IgG 271, IgA 40, IgM 36• T&B Cell SubsetsAbsolutePercentLymph 2804 65CD3+ 505 18CD19+ 84 3CD4_+ 365 13CD8+ 140 5CD3-/16+56+2159 77
Differential Diagnosis• ID work up negative (EBV, CMV, parvo,HSV, HIV, blood, urine, stool cultures)• What are the possible diagnoses now?• Any additional work up?
Laboratory Results• Ferritin: 3928• Soluble IL2R: 17155• Triglycerides: 201• NK Cell FunctionNK %CytotoxicityResultNormal50:1 26 >2025:1 22 >1012:1 14 >56:1 11 >1NK Lyticunits17.7 >2.6CD16/56 % 67 2-13Bone Marrow Biopsy
Differential for HemophagocyticHistiolymphocytosis (HLH)Familial HLHPrimary HLH% of Familial HLHcasesProtein/GeneFHL1 ? UnknownFHL2 20-40 Perforin/PRF1FHL3 10-30 (Scandinavian) MUNC13-4/UNC13DFHL4 10-20 (Kurdish) Syntaxin-11/STX11FHL5 ? MUNC18-2/STXBP2Immunodeficiency Incidence Protein/GeneXLPXFLHGriscelli syndromeType 240%-60% withidentified mutationRareSAP/SH2D1AXIAP/BRIC4RAB27AChediak-Higashi
Differential for HemophagocyticHistiolymphocytosis (HLH)Secondary HLHInfectionsVirusesBacteriaParasitesFungiNon-infectionsMalignancyRheumatology(MAS)TherapyCommon Inciting AgentsAdenovirus, enterovirus, hespesvirus (HSV, CMV,EBV, HHV-6, HHV-8, VZV), HIV, influenza, measles,parvovirus B19Mycobacterium tuberculosis, Brucella, Coxiella,rickettsioses, gram-negative/positive bacteremiaPlasmodium, LeishmaniaHistoplasma capsulatum, Penicillium, FusariumLymphoma, pre-B ALLJIA, SLE, KawasakiCommon Inciting AgentsHAART, BMT, solid organ transplant, chemotherapy
Griscelli Syndrome• Autosomal recessive• Hypopigmentation: partial albinism• Neurologic involvement: usually due tolymphohistiocytic infiltration• Absence of giant granules in histology differentiatesit from Chediak-Higashi• Mutations– Type 1 (MYO5A unconventional myosin): noimmunodeficiency or HLH, neurological symptoms– Type 2 (RAB27A GTP binding protein of Ras family):HLH with neurologic involvement– Type 3 (MLPH melanophilin): albinism alone, noimmunodeficiency or neurologic complications
<strong>Clinical</strong> Course After Diagnosis• RAB27 homozygous mutation• HLA 10/10 matched related BMT with motheras the donor (she was positive for trait butnegative for disease)• BMT complications: GVHD grade II withmucositis, hypertension, and prolonged treatmentwith antimicrobials• Died 3 mo post transplant, with embolic eventsleading to renal and cardiac failure
References• Janka GE. Familial and AcquiredHemophagocytic Lymphohistiocytosis. Annu.Rev. Med. 2012. 63:233–46• Henter et al. HLH-2004: Diagnostic andTherapeutic Guidelines for HemophagocyticLymphohistiocytosis. Pediatr Blood Cancer2007;48:124–131